Health aspects of the use of beta-2 adrenergic drugs in animal production.
In the zootechnical field, there is a strong need to correlate analytical results with biological effects of beta-2 adrenergic agonist drugs on animal health, food processing and human toxicology, taking into account the peculiarity of their administration (long-term treatments with doses tenfold as high as the therapeutical ones). The opportunity to use ELISA tests to readily detect illegal treatments, suspected on the basis of clinical and inspective data, can allow appropriate preventive medicine action by monitoring the food chain during its early steps (in living animals). Sanitary implications will not be limited only to serious clinical signs confirmed by analyses, but should also lead to educational programmes intended for farmers, showing them the main obvious risks in animal production associated with beta-2 agonist side-effects.